Akiko Tanaka

Akiko Tanaka

Auto-generated profile, based on publicly available information

Akiko Tanaka

Department of Pharmaceutical Technology, Kobe Pharmaceutical University

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2018 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
ATAkiko Tanaka
Akiko Tanaka
TFTomoyuki Furubayashi
Tomoyuki Furubayashi
MAMari Arai
Mari Arai
Daisuke InoueDaisuke Inoue
Daisuke Inoue
SKShunsuke Kimura
Shunsuke Kimura
AYAkira Yamamoto
Akira Yamamoto

13 January 2007 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
AYAya Yokota
Aya Yokota
MTMasaki Taniguchi
Masaki Taniguchi
YTYuka Takahira
Yuka Takahira
ATAkiko Tanaka
Akiko Tanaka
KTKoji Takeuchi
Koji Takeuchi

1 December 2018 in Biological and Pharmaceutical Bulletin
Verified
Journal Article
Open access
SKShunsuke Kimura
Shunsuke Kimura
AKAkiko Kiriyama
Akiko Kiriyama
ENErika Nishimura
Erika Nishimura
SSShiori Sakata
Shiori Sakata
Daisuke InoueDaisuke Inoue
Daisuke Inoue
TSToshiyasu Sakane
Toshiyasu Sakane
We reported a novel transport mechanism of curcumin, independent of improved solubility, which involved direct contact of amorphous solid particles with the cell membrane. This mechanism has potential as a novel systemic delivery system of poorly water-soluble drugs. In this study, the transport mechanism of furosemide (FUR), which is transported by the same novel mechanism, was examined. In vitro cell permeation studies under air-interface conditions (AICs) revealed that the permeation from powders sprayed on cell monolayers was significantly higher than that under liquid-covered conditions (LCCs) from their solutions. The permeation from amorphous solid particles was faster than that from crystals. Similar results were derived from in vitro studies using an artificial membrane, with which the permeation of FUR could be examined without water. These findings clearly indicated that the transport mechanism of FUR is the same as that of curcumin. For the application of this new transport mechanism, the in vivo absorption of FUR was examined after pulmonary insufflation, which allows the solid particles to make direct contact with the epithelial cells. Pulmonary absorption of FUR from the amorphous powder was almost complete and was faster than that after intragastric administration of the solution, suggesting that FUR was absorbed from the lung by the same mechanism as the in vitro study. This new transport mechanism, which is independent of water dissolution, could be exploited to develop a novel delivery system for poorly water-soluble drugs, using pulmonary powder inhalation.

1 April 1998 in Infant Behavior and Development
Verified
Journal Article
Closed access
EAEmma K. Adam
Emma K. Adam
ATAkiko Tanaka
Akiko Tanaka
LBLaurie Brodersen
Laurie Brodersen
MGMegan R. Gunnar
Megan R. Gunnar